TrademarkDir
DENKI
LIVE

Serial Number

79252701

Owner

PHARMALEADS

Attorney

Dianne M. Smith-Misemer

Filing Date

Jan 15, 2019

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

DENKI Trademark

Serial Number: 79252701 • Registration: 6004513

DENKI is a trademark filed by PHARMALEADS on January 15, 2019. The trademark is classified under Class 1 (Chemicals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

PHARMALEADS (4 trademarks)

Paris BioPark 11 Rue Watt
Paris 75016 , FR

Entity Type: 99

Trademark Details

Filing Date

January 15, 2019

Registration Date

March 10, 2020

Published for Opposition

December 24, 2019

Goods & Services

Chemical products for use in industry and science, [ all aforementioned goods only for dual enkephalinase inhibitors ] * all the aforesaid goods exclusively in connection with dual enkephalinase inhibitors *

scientific technological services namely, scientific research, analysis, testing in the field of endogenous opioid peptides; scientific research and design and development services related to the inhibition of the degradation of endogenous opioid peptides, all in the medical and pharmaceutical fields; development of medicines for [ others ] * third parties * ; medicine discovery services in the nature of development of pharmaceutical preparations, [ all aforementioned services only for dual enkephalinase inhibitors ] * all the aforesaid services exclusively in connection with dual enkephalinase inhibitors *

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Mar 10, 2025 REM3
CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
Jul 21, 2021 CORR
CORRECTION TRANSACTION RECEIVED FROM IB
Jul 10, 2021 CRCV
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Jan 5, 2021 INNA
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Jan 4, 2021 INPR
FINAL DECISION TRANSACTION PROCESSED BY IB
Aug 7, 2020 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jul 20, 2020 FICS
FINAL DISPOSITION PROCESSED
Jul 20, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 10, 2020 FICR
LIMITATION FROM THE IB EXAMINED AND ENTERED
Apr 24, 2020 LIME
CORRECTION UNDER SECTION 7 - PROCESSED
Apr 23, 2020 COC.
ASSIGNED TO PARALEGAL
Apr 23, 2020 PLGL
LIMITATION OF GOODS RECEIVED FROM IB
Mar 20, 2020 LIMG
REGISTERED-PRINCIPAL REGISTER
Mar 10, 2020 R.PR
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Feb 4, 2020 LIMN
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Jan 22, 2020 LIMN
NOTIFICATION PROCESSED BY IB
Jan 3, 2020 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 24, 2019 NPUB
PUBLISHED FOR OPPOSITION
Dec 24, 2019 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 18, 2019 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Dec 18, 2019 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 4, 2019 NONP
LIMITATION OF GOODS RECEIVED FROM IB
Nov 29, 2019 LIMG
LIMITATION OF GOODS RECEIVED FROM IB
Nov 22, 2019 LIMG
ASSIGNED TO LIE
Nov 15, 2019 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 13, 2019 CNSA
EXAMINER'S AMENDMENT ENTERED
Nov 13, 2019 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 13, 2019 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 13, 2019 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 13, 2019 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 25, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 24, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 24, 2019 TROA
REFUSAL PROCESSED BY IB
May 18, 2019 RFNP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 2, 2019 RFCS
REFUSAL PROCESSED BY MPU
May 2, 2019 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 10, 2019 RFCR
NON-FINAL ACTION WRITTEN
Apr 9, 2019 CNRT
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Apr 8, 2019 RFWR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 28, 2019 RFCR
NON-FINAL ACTION WRITTEN
Mar 27, 2019 CNRT
ASSIGNED TO EXAMINER
Mar 27, 2019 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 5, 2019 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 27, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 21, 2019 REPR

Related Trademarks

More from this Owner

FLUOFAST

FLUOFAST

FLUOFAST

FLUOFAST

FLUOFAST

FLUOFAST

PHARMALEADS

PHARMALEADS

PHARMALEADS

PHARMALEADS

PHARMALEADS

PHARMALEADS